Evaluation of the Evolution of Pregnancies in the First Trimester Following a Medically Assisted Procreation (MAR) Management During a COVD-19 Pandemic Period

University Hospital, Strasbourg, France1 site in 1 country700 target enrollmentAugust 1, 2020

ConditionsCovid-19

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Covid-19
Sponsor: University Hospital, Strasbourg, France
Enrollment: 700
Locations: 1
Primary Endpoint: Study of the evolution of pregnancies in the first trimester following MAR management during a COVD-19 pandemic period
Status: Completed
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Because of the physiological changes inherent in pregnancy, pregnant women with lower respiratory tract infections often have more worrisome outcomes compared to non-pregnant individuals, including a higher rate of hospital and intensive care unit admissions.

Registry

clinicaltrials.gov

Start Date

August 1, 2020

End Date

December 31, 2020

Last Updated

5 years ago

Study Type

Observational

Sex

Female

Investigators

Sponsor

University Hospital, Strasbourg, France

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patient included in a Medically Assisted Procreation (MAR) protocol aged between 18 and 43 years of age
•Patient who has already signed a consent to management